These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684 [TBL] [Abstract][Full Text] [Related]
8. Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study. Denis MA; Cosyns JP; Persu A; Dewit O; de Galocsy C; Hoang P; Maldague P; Wallemacq P; Zerbib F; Fiasse R Eur J Clin Invest; 2013 Mar; 43(3):292-301. PubMed ID: 23373823 [TBL] [Abstract][Full Text] [Related]
9. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Hawkins PN; Richardson S; Vigushin DM; David J; Kelsey CR; Gray RE; Hall MA; Woo P; Lavender JP; Pepys MB Arthritis Rheum; 1993 Jun; 36(6):842-51. PubMed ID: 8507227 [TBL] [Abstract][Full Text] [Related]
10. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172 [TBL] [Abstract][Full Text] [Related]
11. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis. Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719 [TBL] [Abstract][Full Text] [Related]
12. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373 [TBL] [Abstract][Full Text] [Related]
13. [Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature]. Elloumi H; Ben Slama A; Arfaoui D; Ghouma M; Sfar S; Ajmi S Tunis Med; 2006 Apr; 84(4):253-5. PubMed ID: 16832997 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. Hawkins PN; Lavender JP; Pepys MB N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176 [TBL] [Abstract][Full Text] [Related]
15. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature. Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697 [TBL] [Abstract][Full Text] [Related]
16. [A case of systemic AA amyloidosis complicating Crohn's disease]. Muro K; Kobayashi M; Shimizu Y; Kikuchi S; Yamaguchi N; Inadome Y; Watanabe T; Koyama A Nihon Jinzo Gakkai Shi; 1998 May; 40(4):284-9. PubMed ID: 9654912 [TBL] [Abstract][Full Text] [Related]
17. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437 [TBL] [Abstract][Full Text] [Related]
18. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature. Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992 [TBL] [Abstract][Full Text] [Related]